Last updated: February 19, 2026
Pralidoxime chloride is used primarily as an antidote for organophosphate poisoning. It is manufactured globally, mostly by chemical and pharmaceutical companies with specialized production capabilities.
Major Suppliers
| Company Name |
Country |
Manufacturing Capabilities |
Packaging & Forms |
Notes |
| Mylan N.V. |
Netherlands/USA |
Large-scale production, certified for global export |
Injection, vial, ampoule |
Widely available in global markets |
| Hikma Pharmaceuticals |
UK |
Multiple formulations, including injectable forms |
Injection, injectable |
Supplies to Europe, Middle East, North Africa |
| Teva Pharmaceutical Industries |
Israel |
Extensive manufacturing, generic provider |
Injection, vials |
Approvals in multiple regulatory regions |
| B Saraswat Chemicals |
India |
Focused on API production, including pralidoxime |
API, bulk drug |
Serves Indian and emerging markets |
| Sun Pharmaceutical Industries |
India |
Large API and finished dosage unit manufacturing |
Injection, injectable |
Has WHO-GMP and other certifications |
Regional Suppliers and API Producers
- India: Dominates API production for pralidoxime chloride. Companies include B Saraswat Chemicals, IPCA Laboratories, and S.D. Fine Chemicals.
- China: Certain producers supply API for export, with companies such as Zhejiang Medicine.
- Europe/USA: Fewer manufacturers, mainly large pharmaceutical companies with strict regulatory approval processes.
Supply Chain Overview
Pralidoxime chloride is primarily produced as an API, supplied in bulk to pharmaceutical companies for formulation into injectable drugs. The supply chain involves:
- Raw materials including chloromethanes and other chemical intermediates.
- API synthesis requiring controlled chemical processes.
- Packaging into vials or ampoules under sterile conditions.
- Regulatory compliance to meet Good Manufacturing Practices (GMP).
Regulatory Considerations
Manufacturers must comply with local and international standards such as:
- FDA regulations (United States)
- EMA guidelines (European Union)
- WHO-GMP standards (Global platforms for generics and hospital supply)
Compliance influences market approval and commercialization.
Supply Market Dynamics
- Market dominated by Indian and Chinese API producers.
- Limited number of licensed pharmaceutical manufacturers producing finished injectable products.
- Price fluctuations influenced by raw material costs, regulatory changes, and demand shifts.
Key Points
- No single dominant supplier controls global supply.
- Indian API manufacturers serve both domestic and export markets.
- Large pharmaceutical companies globally manufacture finished dosage forms.
- Supply chain risks include raw material shortages, regulatory delays, and geopolitical issues.
Key Takeaways
- Pralidoxime chloride is supplied mainly by Indian and Chinese API producers, with some regional manufacturers supporting local markets.
- Large pharmaceutical firms handle formulation and distribution, complying with regulatory standards like FDA and EMA.
- Market stability relies on the capacity of API producers and regulatory environments.
- Supply chain disruptions may impact availability and pricing, especially in regions dependent on imports.
- The product’s manufacturing complexity limits the number of active API producers, concentrating supply risks.
FAQs
1. Who are the top API manufacturers of pralidoxime chloride?
Indian companies such as B Saraswat Chemicals and S.D. Fine Chemicals lead in API production. Chinese companies like Zhejiang Medicine also supply globally.
2. Is pralidoxime chloride available from generic suppliers?
Yes, multiple generic manufacturers produce pralidoxime chloride, often targeting hospitals and emergency use.
3. Which countries have regulatory approvals for pralidoxime chloride formulations?
The United States (FDA), European Union (EMA), India (DCGI), and WHO-approved manufacturers meet GMP standards globally.
4. Are there specialty suppliers for sterile injectable formulations?
Yes, large pharmaceutical companies like Mylan, Teva, and Hikma produce sterile injectable forms for global markets.
5. What factors influence the cost of pralidoxime chloride?
Raw material prices, manufacturing scale, regulatory compliance costs, and market demand affect pricing.
Citations
- U.S. Food and Drug Administration. (2022). Drug Approvals and Guidelines.
- European Medicines Agency. (2022). Regulation and Approval of Medications.
- World Health Organization. (2021). Good Manufacturing Practices for Active Pharmaceutical Ingredients.
- Indian Pharmacopoeia Commission. (2020). API Standards.
- Chinese Pharmacopoeia. (2020). API Production and Quality Standards.
